Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011
- PMID: 29124624
- PMCID: PMC10068427
- DOI: 10.1007/s10995-017-2395-8
Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011
Abstract
Background Small for gestational age (SGA) birth is associated with poor long-term health outcomes. It is unclear whether maternal antihypertensive medication increases risk of SGA independently of maternal hypertension. Methods We analyzed associations between maternal hypertension and antihypertensive medication use and SGA among non-malformed singleton controls in the National Birth Defects Prevention Study. We defined SGA as birthweight < 10th percentile for a given gestational age, sex, race/ethnicity, and parity. We included 1045 SGA and 10,019 non-SGA births. We used logistic regression to calculate adjusted odds ratios (AORs) and 95% confidence intervals (CIs). We assessed interaction between hypertension, antihypertensive use, and maternal race/ethnicity and age. Results Overall, 122 (11.7%) SGA and 892 (8.9%) non-SGA mothers reported hypertension and 21 (2.0%) SGA and 154 (1.5%) non-SGA mothers reported antihypertensive use. The most commonly reported medications were centrally-acting antiadrenergics, β-blockers, calcium channel blockers, and diuretics. Compared to normotensive pregnancies, maternal hypertension, regardless of treatment (AOR, 1.49 [95% CI, 1.20, 1.86]), and untreated maternal hypertension [AOR, 1.46 (95% CI, 1.15, 1.86)] were associated with SGA. We observed a positive, but not significant, association between antihypertensive use and SGA. SGA risk varied by maternal race/ethnicity, being highest among Hispanic mothers, and age, being highest among mothers ≥ 35 years, but statistical tests for interaction were not significant. Conclusions Consistent with the literature, our findings suggest that maternal hypertension slightly increases SGA risk. We did not observe an appreciably increased SGA risk associated with antihypertensive medication use beyond that of the underlying maternal hypertension.
Keywords: Antihypertensive medication; Hypertension; National Birth Defects Prevention Study; Pregnancy; Small for gestational age.
Conflict of interest statement
Similar articles
-
Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.BJOG. 2014 Aug;121(9):1090-6. doi: 10.1111/1471-0528.12678. Epub 2014 Mar 17. BJOG. 2014. PMID: 24628701
-
Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes.J Matern Fetal Neonatal Med. 2024 Dec;37(1):2305675. doi: 10.1080/14767058.2024.2305675. Epub 2024 Jan 30. J Matern Fetal Neonatal Med. 2024. PMID: 38290827
-
Does Maternal Exposure to Secondhand Tobacco Smoke During Pregnancy Increase the Risk for Preterm or Small-for-Gestational Age Birth?Matern Child Health J. 2018 Oct;22(10):1418-1429. doi: 10.1007/s10995-018-2522-1. Matern Child Health J. 2018. PMID: 29574536
-
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD002252. doi: 10.1002/14651858.CD002252.pub4. Cochrane Database Syst Rev. 2018. PMID: 30277556 Free PMC article.
-
Impact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta-Analysis.J Am Heart Assoc. 2021 May 4;10(9):e018494. doi: 10.1161/JAHA.120.018494. Epub 2021 Apr 17. J Am Heart Assoc. 2021. PMID: 33870708 Free PMC article.
Cited by
-
Adverse Maternal and Infant Outcomes in Women With Chronic Hypertension in France (2010-2018): The Nationwide CONCEPTION Study.J Am Heart Assoc. 2023 Mar 7;12(5):e027266. doi: 10.1161/JAHA.122.027266. Epub 2023 Feb 27. J Am Heart Assoc. 2023. PMID: 36847049 Free PMC article.
-
Identifying hypertensive disorders of pregnancy, a comparison of two epidemiologic definitions.Front Cardiovasc Med. 2022 Nov 23;9:1006104. doi: 10.3389/fcvm.2022.1006104. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36505381 Free PMC article.
-
Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies.PLoS Genet. 2020 Dec 7;16(12):e1009191. doi: 10.1371/journal.pgen.1009191. eCollection 2020 Dec. PLoS Genet. 2020. PMID: 33284794 Free PMC article.
-
The comparison of perinatal clinical characteristics between severe small for gestational age and mild small for gestational age according to the latest birth curve in China.AJOG Glob Rep. 2024 Dec 4;5(3):100429. doi: 10.1016/j.xagr.2024.100429. eCollection 2025 Aug. AJOG Glob Rep. 2024. PMID: 40641835 Free PMC article.
-
Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study.Am Heart J. 2024 Dec;278:5-13. doi: 10.1016/j.ahj.2024.08.010. Epub 2024 Aug 22. Am Heart J. 2024. PMID: 39178979
References
-
- Ananth CV, Peedicayil A, & Savitz DA (1995). Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology, 6(4), 391–395. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical